141 related articles for article (PubMed ID: 31359156)
1. Minimum Interfacial Bonding Strength for Bilayer Tablets Determined Using a Survival Test.
Chang SY; Sun CC
Pharm Res; 2019 Jul; 36(10):139. PubMed ID: 31359156
[TBL] [Abstract][Full Text] [Related]
2. Interfacial bonding in formulated bilayer tablets.
Chang SY; Sun CC
Eur J Pharm Biopharm; 2020 Feb; 147():69-75. PubMed ID: 31870828
[TBL] [Abstract][Full Text] [Related]
3. Influence of compaction properties and interfacial topography on the performance of bilayer tablets.
Kottala N; Abebe A; Sprockel O; Akseli I; Nikfar F; Cuitiño AM
Int J Pharm; 2012 Oct; 436(1-2):171-8. PubMed ID: 22728259
[TBL] [Abstract][Full Text] [Related]
4. Tensile and shear methods for measuring strength of bilayer tablets.
Chang SY; Li JX; Sun CC
Int J Pharm; 2017 May; 523(1):121-126. PubMed ID: 28284920
[TBL] [Abstract][Full Text] [Related]
5. A formulation strategy for solving the overgranulation problem in high shear wet granulation.
Osei-Yeboah F; Zhang M; Feng Y; Sun CC
J Pharm Sci; 2014 Aug; 103(8):2434-40. PubMed ID: 24985120
[TBL] [Abstract][Full Text] [Related]
6. Comparison of breaking tests for the characterization of the interfacial strength of bilayer tablets.
Castrati L; Mazel V; Busignies V; Diarra H; Rossi A; Colombo P; Tchoreloff P
Int J Pharm; 2016 Nov; 513(1-2):709-716. PubMed ID: 27717917
[TBL] [Abstract][Full Text] [Related]
7. The impact of roller compaction and tablet compression on physicomechanical properties of pharmaceutical excipients.
Iyer RM; Hegde S; Dinunzio J; Singhal D; Malick W
Pharm Dev Technol; 2014 Aug; 19(5):583-92. PubMed ID: 23941645
[TBL] [Abstract][Full Text] [Related]
8. Effects of excipients and curing process on the abuse deterrent properties of directly compressed tablets.
Rahman Z; Zidan AS; Korang-Yeboah M; Yang Y; Siddiqui A; Shakleya D; Khan MA; Cruz C; Ashraf M
Int J Pharm; 2017 Jan; 517(1-2):303-311. PubMed ID: 27956191
[TBL] [Abstract][Full Text] [Related]
9. Latent structure analysis in the pharmaceutical process of tablets prepared by wet granulation.
Uehara N; Hayashi Y; Mochida H; Otoguro S; Onuki Y; Obata Y; Takayama K
Drug Dev Ind Pharm; 2016 Jan; 42(1):116-122. PubMed ID: 25997364
[TBL] [Abstract][Full Text] [Related]
10. A new brittleness index for compacted tablets.
Sonnergaard JM
J Pharm Sci; 2013 Dec; 102(12):4347-52. PubMed ID: 24258281
[TBL] [Abstract][Full Text] [Related]
11. Relationships between the effective interparticulate contact area and the tensile strength of tablets of amorphous and crystalline lactose of varying particle size.
Sebhatu T; Alderborn G
Eur J Pharm Sci; 1999 Aug; 8(4):235-42. PubMed ID: 10425373
[TBL] [Abstract][Full Text] [Related]
12. Development of a new test for the easy characterization of the adhesion at the interface of bilayer tablets: proof-of-concept study by experimental design.
Busignies V; Mazel V; Diarra H; Tchoreloff P
Int J Pharm; 2014 Dec; 477(1-2):476-84. PubMed ID: 25445527
[TBL] [Abstract][Full Text] [Related]
13. Development of Tablet Formulation of Amorphous Solid Dispersions Prepared by Hot Melt Extrusion Using Quality by Design Approach.
Agrawal A; Dudhedia M; Deng W; Shepard K; Zhong L; Povilaitis E; Zimny E
AAPS PharmSciTech; 2016 Feb; 17(1):214-32. PubMed ID: 26757898
[TBL] [Abstract][Full Text] [Related]
14. A comparison of drug loading capacity of cellactose with two ad hoc processed lactose-cellulose direct compression excipients.
Casalderrey M; Souto C; Concheiro A; Gómez-Amoza JL; Martínez-Pacheco R
Chem Pharm Bull (Tokyo); 2004 Apr; 52(4):398-401. PubMed ID: 15056951
[TBL] [Abstract][Full Text] [Related]
15. Physico-Mechanical Properties of Coprocessed Excipient MicroceLac® 100 by DM(3) Approach.
Haware RV; Kancharla JP; Udupa AK; Staton S; Gupta MR; Al-Achi A; Stagner WC
Pharm Res; 2015 Nov; 32(11):3618-35. PubMed ID: 26055403
[TBL] [Abstract][Full Text] [Related]
16. Evaluation of the performance characteristics of bilayer tablets: Part II. Impact of environmental conditions on the strength of bilayer tablets.
Kottala N; Abebe A; Sprockel O; Bergum J; Nikfar F; Cuitiño AM
AAPS PharmSciTech; 2012 Dec; 13(4):1190-6. PubMed ID: 22965660
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of microcrystalline cellulose prepared from sisal fibers as a tablet excipient: a technical note.
Bhimte NA; Tayade PT
AAPS PharmSciTech; 2007 Feb; 8(1):8. PubMed ID: 17408230
[No Abstract] [Full Text] [Related]
18. Evaluation of manufacturing process parameters causing multilayer tablets delamination.
Bellini M; Walther M; Bodmeier R
Int J Pharm; 2019 Oct; 570():118607. PubMed ID: 31421200
[TBL] [Abstract][Full Text] [Related]
19. Investigation of compressibility and compactibility parameters of roller compacted Theophylline and its binary mixtures.
Hadžović E; Betz G; Hadžidedić S; El-Arini SK; Leuenberger H
Int J Pharm; 2011 Sep; 416(1):97-103. PubMed ID: 21704142
[TBL] [Abstract][Full Text] [Related]
20. Predictive model for tensile strength of pharmaceutical tablets based on local hardness measurements.
Juban A; Nouguier-Lehon C; Briancon S; Hoc T; Puel F
Int J Pharm; 2015 Jul; 490(1-2):438-45. PubMed ID: 26043825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
